Performance Measurement Network

List of All Questions in the FAQ Database

Clinical Specification Questions

Question Related to
Pre-transfusion platelet count allowable value BM-04b
Reason for Not Prescribing Antithrombotic / Anticoagulation at Discharge STK-02
Consideration of PRADAXA as anticoagulation therapy for patients with atrial fibrillation STK-03
DVT Prophylaxis and Ambulation STK, STK-01
Documentation added to D/C summary after discharge STK-6
In the Operating Room, is "Estimated Blood Loss" for PRBC'S considered transfusion criteria? BM-02
Which version of the specifications should be used for stroke data collection? STK
MER code for combined billing for two hospitals-TSC CSTK, CSTK-08
MER Eligibility CSTK
If tPA is given at an outside hospital by our Critical Transport Team, should we take credit? STK, STK-04
Is Xarelto an antithromotic for use in Stroke? Can it be used for antithrombotic med at discharge? STK, STK-02
Questions about sampling? ACHF
Date Last Known Well STK
CSTK-01 Procedures and Timing 1 calculation CSTK-01
Reason for not giving Nimodipine within 24 hours CSTK
Time Last Known Well - Conflicting Physician Documentation STK-04
Time NIHSS performed CSTK-01
History of low vertical incision documented BUT no documentation of classical incision. PC-01
Time of the teleneurology NIHSS CSTK-01
Dabigatran (PRADAXA use in Stroke Patients) STK
Comprehensive Stroke (CSTK Sub-Populations) CSTK
Importance of exclusive breast milk feeding PC
How should Last Known Well be abastracted when there is conflicting documentation in the medical record? STK-04
Will files be rejected if all procedure codes do not have a procedure time? CSTK, CSTK-01, CSTK-03
Activity specifics ACHF
STK-6 "Evidence of Atherosclerosis" STK
Multiple Procedure Times CSTK, CSTK-01
Does Appendix H, Table 2.2 exclude ambulatory stroke patients from the VTE prophylaxis? STK
ABstraction for Date Last Known Well STK
Can estimated blood loss (EBL be used for the data element pre-transfusion hemoglobin/hematocrit.) BM-02
Stroke Measure Requirements STK
Sampling Requirements for CSTK CSTK
Can I use VTE used during the Observation, given prior to hospital admission STK-1
Will Primary Stroke Certification continue? STK
How should we abstract thrombolytic administration in the 3 to 4.5 hr timeframe when a reason for not administering existed within 3 hrs? STK, STK-04
What dose of enoxaparin is acceptable for use as antithrombotic therapy. STK-2, STK-5
Stroke core measure data for PSC hospitals STK
Primary Stroke Certification and Transition to Stroke Core Measures STK
Continuing Care Plan-Discharge Medications Indications for Use HBIPS
Failed Attempt at Thrombectomy CSTK-08, CSTK-11, CSTK-12
Transfer between the Psychiatric Unit and Acute Care Unit HBIPS
Why are patients that receive t-PA in the ED and then transferred to another hospital excluded from STK-4? STK-04
Please submit all Emergency Department measure questions directly to QnetQuest.org ED, ED-1, ED-2
AMA and Number of Antipsychotic Meds Prescribed at Discharge HBIPS-4, HBIPS-5
Follow-up to UserQuestion102705 CSTK
ICD-9-CM Code 433.10 STK
Clarification of data elements needed CSTK-05b, CSTK-07
Define who is considered a stroke team for STK 4. STK
Reason for Not Prescribing Anticoagulation Therapy at Discharge STK-03
Documentation Compliance for IV t-PA STK, STK-04
SUB 2 SUB
What is the Date and Time of Last Well Known? STK-04
Sampling Requirements for CSTK CSTK
Reason for not prescribing antithrombotic therapy at hospital discharge STK
CSTK 02, 05, and 06 Measures CSTK-01, CSTK-02, CSTK-05, CSTK-06
Documentation of Last Known well STK, STK-4
Can the following note be used as a Reason for Not Prescribing Anticoagulation Therapy? STK-03
Definition of validated and non-validated screening tool for substance use SUB-01
Patient Referral to Next Level of Care Provider HBIPS
Does CSTK - 03 include directly admitted transfers (that bypass ED?) CSTK-03
Are patients admitted for elective basilar stenting excluded from the stroke chart audits? STK
Last Known Well Y/N? STK-4
Statin therapy for patients 75yrs and older STK
Stroke after admission-arrival to skin puncture CSTK -09 CSTK
Date/Time of First Pass for CSTK-7 CSTK
WIll the new medication Pradaxa be acceptable as an anticoagulant at discharge? STK, STK-03
Last Known Well STK, STK-04
What are the benchmarks for the new Outpatient Stroke Core Measures? STK-OP
If a physician writes an order for SCDs, is this sufficient to select 'Yes' for VTE Prophylaxis? STK-01, VTE-01
Should 'Yes' or 'No' be selected for IV Thrombolytic Initiation? STK
SCIP Inf-9 Urinary catheter removed on Postoperative Day 1 (POD 1 or Postoperative Day 2 (POD 2) with day of surgery being day zero ) SCIP, SCIP Inf-9
Multiple TICI reperfusion grades CSTK-08
For Q1 2013 fVTE and Oral Factor Xa inhibitor in Stroke patients. STK-01
Question regarding the new STK OP 1 Measure STK-OP
Admission Date STK-01
If the patient enters the ED as a potential or actual TIA or hemorrhagic stroke patient, are the ED physicians required to document why the patient did not have IV thrombolytics initiated? STK
Version 4.4 - Time Last Known Well and Reason Extending IV Thrombolytic STK-04
Reason for Not Initiating IV Thrombolytic-conflicting GWTG instructions STK-04
Is this considered a stroke clinical trial patient? STK
Pneumonia diagnosis: ED/Direct Admint PN
Lovenox in reference to STK-2, STK-5, and STK-3 STK-2, STK-3, STK-5
Can a patient undergoing Cardiac Surgery who received RBC's, FFP and Platelets be counted for more than one measure? BM
Reason for No VTE Prophylaxis STK, STK-01
What should we do when conflicting or multiple times of last known well are documented? STK-04
Time Last Known Well STK
HBIPS- Restraint and Seclusion in ED HBIPS-3
Non Aneurysmal SAH Documentation CSTK-06
First Pass of a Mechanical Reperfusion Device / First Pass Time CSTK, CSTK-05
Are patients who have ischemic stroke occured after hospital arrival included in CSTK-01 population CSTK-01
Statins at Discharge STK-06
Pradaxa (dabigatran prescribed at discharge) STK-02
What are the recommendations for VTE prophylaxis for stroke patients? STK-01
Will Evidence of Atherosclerosis remain a data element? STK-06
Patient Population CSTK
Documentation for tPA exclusion STK, STK-04
Stroke Education Documentation Examples STK-08
Stroke Module STK
Are the following examples acceptable Reasons for Not Prescribing Anticoagulation and Antithrombotic Therapy at Discahrge? STK, STK-02
Last Known Well STK-04
Are retired Stroke Core Measures still required for comprehensive stroke centers? STK
Use of Sweet-Ease速 and PC-05 (Exclusive Breast Milk Feeding) PC-05
Must the patient refuse both pharmacological and mechanical VTE prophylaxis to count as a reason for no prophylaxis? STK-01
Why is ICD-9-CM Principal Diagnosis Code 436 used for ischemic stroke? STK
Next Level of Care Provider Same as Hospital Provider HBIPS
Appointment for Follow Up/ Release of Information HBIPS, HBIPS-7
Reason for Extending the Initiation of IV Thrombolytic STK, STK-04
Initial Date/time of NIHSS teleneurologist CSTK, CSTK-01
Footling breech code 652.81 as an exclusion for PC-02 PC-02a
How should we abstract pharmacological VTE prophylaxis when the patient is NPO? STK
Reason for Not Administering Antithrombotic Therapy? STK
Hunt and Hess & ICH Score Documentation CSTK-03
Assessed for Rehabaliitation Services STK-10
Discharge Medications and Indication for Use HBIPS-6, HBIPS-7
OBS: remains in the ED or transfer to another unit not in the ED STK-OP
How to Answer Questions on Advanced Stroke Tab Intent to Perform MER CSTK-08
TEDS for VTE Prophylaxis STK, STK-01
Referral to Next Level of Care HBIPS
Positive over negative findings STK-OP
NIHSS versus mNIHSS CSTK-05
How to abstact Last Known Well when there is too much information? STK
Procedure codes for HF outpatients ACHF
Reason for extending IV tPA STK-4
Is heparin 5000U SQ acceptable for antithrombitic administered by end day 2 STK
Thrombolytic therapy administered at satellite ED prior to hospital arrival STK
doucumentation of ich and hunt hess CSTK-03
Procedure Time Inclusion Terms CSTK-03
Mother's choice not to breast feed PC-05
Data Element- Violence Risk to Self HBIPS
Why does a patient on another lipid-lowering medication qualify and fail statin prescribed at discharge? STK-06
Reason for Not Initiating IV Thrombolytic STK
Patients transferred after t-PA STK
Reason for No VTE Prophylaxis - Hemorrhagic Stroke Patient STK-01
Will Evidence of Atherosclerosis remain a STK-6 data element? STK
STK 10 Assessed for rehabilitation STK-10
Positive Brain Image CSTK
Last known well when symptoms resolve then reoccur STK
Arrival time Abstraction. CSTK-11
HBIPS-1 Timeframe for Screening Questions HBIPS
STK-10 Assessed for Rehabilitation Services STK-10
Statin prescibed the day after discharge STK-06, STK-08
Inter-rater Reliability and Chart Re-asbstraction STK
Is the ambulatory patient considered low risk for VTE? STK
Elective Carotid Intervention STK
How is Length of Stay (LOS calculated for STK-1?) STK-01
Time Last Known Well is after hospital arrival STK-04
What value should be selected when VTE prophylaxis is administered several days after admission? STK
Can an addendum be made to a pt's chart that has been d/c - Physician did not place the hunt & hess. CSTK
CSTK4 documentation time? CSTK-04
NIHSS Timed After Discharge CSTK-01
PSC Certified Hospitals: Sampling Methodology to Use for CSTK 1 for 2019 STK
Clarification of CSTK-1 Measure Population Requirements CSTK-01
HBIPS Event Dates Prior to Admission HBIPS
SCIP- Neuraxial Anesthesia- Epidural for pain control placed post-op SCIP
What constitutes a failed thrombectomy CSTK-11
Exclusive breast milk feeding definition PC
Continuing Care Plan Document Questions HBIPS
Transmission of Continuing Care Plan (CCP) HBIPS, HBIPS-7
Follow-up to UserQuestionId03Vte101043 VTE-05
First NIHSS performed days after admission CSTK-01
Please submit all CMS mortality measure questions directly to QnetQuest.org MORT
Why is a Reason for No VTE Prophylaxis needed with graduated compression stockings (GCS/TEDs?) STK, STK-01
EF on admission 15%. Day of discahrge EF 50-55% per ECHO. Do we answer Y for LVSD<40 . ACHF
If the admitting diagnosis is not stroke, can the case be excluded from STK-4? STK-04
Sampling Methodology for Stroke STK
What is the Admission Date? STK
Late Coded Stroke STK-4 and STK-5 STK, STK-4
Functional Status at Discharge ACHF
When mutiple ejection fractions (EF are documented in the medical record, which value should we use?) ACHF
CSTK 4 Denominator Population CSTK-04
Small vessel disease as Evidence of Atherosclerosis STK, STK-06
Can we use E/M code 99211? ACHF
Reason for No Anticoagulation Therapy Prescribed at Discharge STK-03
Earliest Reperfusion Procedure Date/Time for transferred patients CSTK-01
Patient Receiving Continuing Care Plan Only HBIPS-6, HBIPS-7
ICH score documentation CSTK-03b
Dietary Advice "consistent amount" of foods with Vitamin K rather than avoidance should be advised. VTE-05
Graduated Compression Stocking (GCS) STK
Failed attempt at thrombectomy CSTK-08
When both SCDs and TEDS are applied on the same day , how are they abstracted? STK
Abstraction for Last Known Well STK-04
Elective carotid intervention documentation STK
Discharge Instructions for Activation of Emergency Medical System (EMS (911)) STK-08
Assessed for Rehabilitation STK
Patient Ambulatory At End of Hospital Day 2 STK
Arrival time for transferred patients CSTK-07
Optimal Medication Management ACHF
STK-5 Antithrombotic - LOVENOX SQ STK
Procedures Performed During Hospitalization ACHF
SCIP questions related to the April 2010 manual SCIP
Documentation ofJustification for Multiple Antipsychotic Medications HBIPS
Does all medical record documentation need to be dated and timed? STK
Earliest Aneurysm Repair or Surgical Interv Procedure Time CSTK
Why does a patient treated with another lipid-lowering agent and with LDL < 100 fail the statin measure? STK-06
Recommended ways to obtain mRS CSTK, CSTK-02
Why aren't more exclusions to elective delivery considered? PC
Follow-up to UserQuestionId03Stk100984 STK-04
What version of the Joint Commision manuel will be used starting with January 1, 2010? STK-01, STK-02, STK-03, STK-04, STK-05, STK-06, STK-07, STK-08, STK-09, STK-10, VTE
Comparative Data for Stroke Measures STK
Data Abstraction for "Last Known Well" STK
Rehabilitation Assessment STK
Abstraction for Clinical Trial (STK ) STK
Why aren't there more newborn conditions listed for not exclusively feeding breast milk? PC-05
Stroke that occurs after admission CSTK
Is admission day counted as day 1 for STK-1? STK
CSTK 3 CSTK, CSTK-03
Discharged on Anticoagulation Therapy STK
NIHSS Score Clarification CSTK-01
Will the new AHA recommendation of expasion of the time window for treatment wiht tPA be included in TJC measures/STK4? Other
Hunt & Hess/ ICH score documentation required by tele neuro radiology prior to transfer STK
For patients transfused in Operating Room, how do we respond if there is no "written" order for transfusion. BM-05
Rationale for Code Stroke Form as the Priority Data Source STK-4
Data Element Bisoprolol, Carvedilol, or Sustained-Release Metoprolol Prescribed for LVSD at Discharge has an incomplete sentence ACHF-01
What terms can be used for Comfort Measures Only? STK
Can documentation on a pre-printed stroke order form for VTE Prophylaixs be used as a sufficient reason for no prophylaxis? STK-01
Expired after discharge CSTK-02
Graduated Compression Stockings as VTE Prophylaxis for Stroke Patients (STK-1) VTE-01, STK-1
Last Known Well Version 5.2 STK-4
Is full medication reconciliation required by PSCs to meet the Medication Education measure component? STK-08
Transfer in patients that are intubated CSTK-01
Will certified Primary Stroke Centers be required to report the stroke performance measures as core measures? STK
NIHSS time STK
One Episode of Care and Thrombolytic Therapy Administration STK
Support System ACHF
Why has this indicator has changed to include the word "elective"? STK
Documentation of Stroke Education STK-08
Does the following documentation meet education regarding Risk factors for stroke? STK
Jan 2012 Follow-up monitoring VTE-05
Why are there not more contraindications to vaginal deliveries? PC
Pre-anemia screening BM
Refusal of SCD's STK, STK-01
Is Xarelto (Rivaroxaban an acceptable anticoagulant for STK-3?) STK-03
Documentation for Stroke Education HF-1
Do we need to collect 90 day mRS on pts undergoing CEA/CAS? CSTK
Is it considered CMO if the palliative care consult was done and the patient refuses palliative care the next day? STK
Denominator exclusion population ICD-9 CM diagnosis codes CSTK, CSTK-03
Continuing Care Plan - Reason for Hospitalization HBIPS
Triglyceride >400mg/dL STK
mRS CSTK
First Radiographic Image, CSTK 07 STK
VTE Prophlyaxis - Abstracting of Allowable Values STK-01
Appropriate Justification for Multiple Antipsychotic Meds at DC - Rationale for Allowable Value 4 HBIPS
Nimodipine within 24 hours for non-aneurysmal SAH CSTK, CSTK-06
Follow-up to UserQuestionId03Stk100628 STK
Does a hold on anticoagulation count as a valid reason for not prescribing at discharge? STK-03
Proof that next level of care provider contact information was transmitted with the Transition of Care Record ACHF
STK-4 IV Thrombolytic Therapy STK
Abstraction Tools ASR-OP-1
HBIPS Discharge Status HBIPS
Please submit all outpatient questions to QnetQuest.org OP
COVID-19 CSTK
Stroke VTE Prophylaxis STK-01
What is the Date and Time Last Known Well? STK-04
in 2016, will the vendors still be able to submit STK HCD for STK Certification for our hospitals? STK
STK-1: IV Heparin for VTE Prophylaxis STK, STK-01
what if Pradaxa (dabigatran is prescribed at discharge?) STK-02
can we accept a Drs documentation that it is not a hemorragic transformation CSTK, CSTK-05
Is refusal of all IV's a Reason for Not Initiating IV Throbolytic Therapy? STK-04
Time Last Know Well -Stroke STK
Significance of baseline mRS in calculation of CSTK-10 CSTK-10
CSTK Procedure Times CSTK
Does the reason for not presciribing anticoagulation therapy have to be documented on the dau of discharge? STK-03
Need information about the required import file specifications BM
Lovenox 40mg daily - Antithrombotic Therapy Administered by End of Hospital Day Two STK
Documentation for Rehabilitation Assessment STK-10
Admitted for elective carotid intervention STK
What dosage of Lovenox is suffiecient to meet antithrombotic therapy administered by end of hospital day 2 STK-05
Sampling when both STK and CSTK are collected by a HCO CSTK
Are patients that stroke while an inpatient included in the measure population? STK
Number of cases needed for submission BM
Data abstraction for VTE Prophylaxis when administered prior to admission STK
LDL Measured within first 48 hrs or 30 days prior to hospital arrival STK
Initial Blood Pressure at Hospital Arrival Field Format CSTK-03
STK-6 Data Entry in CMIP for Q1 2010 STK
Are MRI reports an acceptable data source for Evidence of Atherosclerosis? STK-06
Multiple EMRs HBIPS
Who should perform mRS? CSTK-02
activity charting ACHF
Clairfy time to recanalization CSTK, CSTK-07
Can post discharge documentation of a statin prescription be used in abstraction? STK-06
Code 433.10 and Transient Ischemic Attack STK
Written discharge instructions for warfarin therapy VTE-05
PSC CSTK 01 population CSTK, CSTK-01
Earliest principal procedure time/first pass time CSTK
Risk of Violence to Self HBIPS, HBIPS-1
IV Alteplase STK-OP
Stroke Measures STK-7 and STK-9 STK
MER Attempted During this Encounter - Clot Dissolved CSTK-11
Stroke Diagnosed Mid-Hospital Stay STK-5
Psychiatic Care Setting -Patient Inclusion HBIPS
Is there benchmark data available for HBIPS Data? HBIPS, HBIPS-1, HBIPS-1b, HBIPS-1c, HBIPS-1d, HBIPS-1e
Discharge Code and Transfers of Patients STK-OP
PRE-stroke Modified Rankin Indicator question for Cstroke reporting CSTK-02
Documention of Stroke education at discharge, STK-08
When there is a discharge summary and an addendum present in the medical record, which should be used? STK
Unable to Calculate LDL Value Due to High Triglycerides STK-06
Reason for no VTE Prophylaxis - Elevated INR STK, STK-01
What is the purpose of the Missing Branch ('X' Category Assignment for VTE Prophylaxis Date?) STK-01
STK-6 Reason for Not Prescribing a Statin Medication at Discharge STK
Birth Weight suggested Sources PC-06
Reason For Not Administering Antithrombotic By End of Hospital Day 2 STK
thyroid CA PC-01
Is intensive dosing of statin required to meet STK-6? STK
Referral to Next Level of Care Provider-Trasmittal Question HBIPS-6
Antithrombotic Administration after t-PA STK-05
The latest update indicates a favorable mRS as 0 1 or 2 post stroke with pre mRS 3 4 or 5 CSTK
Patients with subsequent admissions to the psychiatric unit HBIPS-1, HBIPS-6, HBIPS-7
Arrival Time for STK, CSTK and STK-OP Measures STK
Retirement of STK-7 Dysphagia Screen STK-07
Can an addendum be added to the medical record? STK-01
Evidence of Atherosclerosis STK
What would I document as Last Known Well? STK, STK-4

Clinical Algorithm Questions

Data Quality Questions

Measure Verification Questions

Measure Verification Questions

Technical Questions

Performance Measurement System Vendor - General Questions

Statistical Questions

%DBQUERY{"TopicType =~ 'UserQuestion' AND Status =~ 'Database'"
 web="%BASEWEB%"
 sort="AnsweredDate"
 format="$expand(QuestionCategory)~$web.$topic~$encode($expand(Question))~$expand(RelatedMIFs)~$formatTime(info.date, '$day $mon $year')"
 separator="##"
}%


---++ Clinical Specification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div>
</noautolink>

---++ Clinical Algorithm Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Data Quality Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID01\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID04\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Measure Verification Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID03a\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Technical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID02\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Performance Measurement System Vendor - General Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID00\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>
---++ Statistical Questions
<noautolink><div class="jqDataTablesContainer  {'bFilter':true, 'bInfo':true, 'bLengthChange': true, 'bPaginate':true, 'aaSorting': [] } ">
%FORMATLIST{"%QUESTIONS%"
  split="##" 
  pattern=".*?~(.*?)~(.*?)~(.*?)~(.*)" 
  include="\bQuestionCategoryID05\b~.*"
  header="$percntTABLE{tablewidth=\"100%\" columnwidths=\"$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\"60%,25%,15%\" else=\"70%,30%\"}$percnt\"}$percnt $n| *Question* | *Related to* |$percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" *Date* | \"}$percnt $n"
  format="| [[$1][$2]] | $3 | $percntIF{\"'%WIKINAME%' ingroup 'AdminGroup'\" then=\" $4 | \"}$percnt"
  separator=" $n"
}%
</div></noautolink>


Copyright © by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Performance Measurement Network? Send feedback
This website is using cookies. More info. That's Fine